D.A. Davidson & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $59.3M | Buy |
272,607
+1,491
| +0.5% | +$331K | 0.36% | 56 |
|
|
2025
Q4 | $61.9M | Buy |
271,116
+20,169
| +8% | +$4.59M | 0.38% | 52 |
|
|
2025
Q3 | $58.1M | Sell |
250,947
-393
| -0.2% | -$80K | 0.37% | 54 |
|
|
2025
Q2 | $46.7M | Sell |
251,340
-1,293
| -0.5% | -$240K | 0.33% | 59 |
|
|
2025
Q1 | $52.9M | Buy |
252,633
+2,807
| +1% | +$546K | 0.43% | 44 |
|
|
2024
Q4 | $44.4M | Buy |
249,826
+3,181
| +1% | +$585K | 0.36% | 50 |
|
|
2024
Q3 | $48.7M | Sell |
246,645
-4,733
| -2% | -$883K | 0.4% | 49 |
|
|
2024
Q2 | $43.1M | Buy |
251,378
+1,930
| +0.8% | +$320K | 0.38% | 51 |
|
|
2024
Q1 | $45.4M | Sell |
249,448
-285
| -0.1% | -$49.1K | 0.41% | 48 |
|
|
2023
Q4 | $38.7M | Sell |
249,733
-4,332
| -2% | -$632K | 0.38% | 50 |
|
|
2023
Q3 | $37.9M | Buy |
254,065
+3,436
| +1% | +$504K | 0.41% | 49 |
|
|
2023
Q2 | $33.8M | Sell |
250,629
-8,341
| -3% | -$1.22M | 0.36% | 54 |
|
|
2023
Q1 | $41.2M | Sell |
258,970
-33,381
| -11% | -$5.1M | 0.46% | 43 |
|
|
2022
Q4 | $47.3M | Buy |
292,351
+2,424
| +0.8% | +$372K | 0.56% | 40 |
|
|
2022
Q3 | $39.1M | Sell |
289,927
-8,523
| -3% | -$1.22M | 0.51% | 41 |
|
|
2022
Q2 | $45.7M | Sell |
298,450
-9,121
| -3% | -$1.39M | 0.57% | 34 |
|
|
2022
Q1 | $49.9M | Sell |
307,571
-11,338
| -4% | -$1.65M | 0.54% | 33 |
|
|
2021
Q4 | $43.2M | Sell |
318,909
-1,785
| -0.6% | -$211K | 0.46% | 43 |
|
|
2021
Q3 | $34.6M | Buy |
320,694
+15,357
| +5% | +$1.75M | 0.4% | 48 |
|
|
2021
Q2 | $34.4M | Buy |
305,337
+13,200
| +5% | +$1.49M | 0.4% | 53 |
|
|
2021
Q1 | $31.6M | Buy |
292,137
+89,126
| +44% | +$9.53M | 0.4% | 54 |
|
|
2020
Q4 | $21.7M | Buy |
203,011
+5,745
| +3% | +$552K | 0.33% | 58 |
|
|
2020
Q3 | $17.3M | Sell |
197,266
-1,252
| -0.6% | -$118K | 0.3% | 64 |
|
|
2020
Q2 | $19.5M | Sell |
198,518
-58,188
| -23% | -$5.12M | 0.36% | 56 |
|
|
2020
Q1 | $19.5M | Buy |
256,706
+18,879
| +8% | +$1.61M | 0.38% | 56 |
|
|
2019
Q4 | $21.1M | Buy |
237,827
+28,648
| +14% | +$2.38M | 0.34% | 60 |
|
|
2019
Q3 | $15.8M | Buy |
209,179
+55,338
| +36% | +$3.79M | 0.28% | 67 |
|
|
2019
Q2 | $11.2M | Sell |
153,841
-3,044
| -2% | -$239K | 0.21% | 84 |
|
|
2019
Q1 | $12.9M | Sell |
156,885
-4,391
| -3% | -$359K | 0.22% | 79 |
|
|
2018
Q4 | $14.9M | Buy |
161,276
+242
| +0.2% | +$21.3K | 0.29% | 64 |
|
|
2018
Q3 | $15.2M | Sell |
161,034
-323
| -0.2% | -$30.6K | 0.27% | 68 |
|
|
2018
Q2 | $14.9M | Buy |
161,357
+6,529
| +4% | +$638K | 0.29% | 63 |
|
|
2018
Q1 | $14.7M | Buy |
154,828
+1,470
| +1% | +$161K | 0.3% | 60 |
|
|
2017
Q4 | $14.8M | Buy |
153,358
+9,777
| +7% | +$921K | 0.31% | 60 |
|
|
2017
Q3 | $12.8M | Buy |
143,581
+2,915
| +2% | +$222K | 0.25% | 91 |
|
|
2017
Q2 | $10.2M | Sell |
140,666
-106,285
| -43% | -$7.15M | 0.23% | 76 |
|
|
2017
Q1 | $16.1M | Buy |
246,951
+16,836
| +7% | +$1.06M | 0.39% | 49 |
|
|
2016
Q4 | $14.4M | Buy |
230,115
+5,727
| +3% | +$350K | 0.33% | 65 |
|
|
2016
Q3 | $14.1M | Buy |
224,388
+26,070
| +13% | +$1.69M | 0.35% | 62 |
|
|
2016
Q2 | $12.3M | Sell |
198,318
-48,596
| -20% | -$2.96M | 0.36% | 62 |
|
|
2016
Q1 | $14.1M | Buy |
246,914
+20,640
| +9% | +$1.15M | 0.44% | 51 |
|
|
2015
Q4 | $13.4M | Buy |
226,274
+101,583
| +81% | +$5.85M | 0.44% | 47 |
|
|
2015
Q3 | $6.78M | Buy |
124,691
+101
| +0.1% | +$6.57K | 0.24% | 83 |
|
|
2015
Q2 | $8.37M | Buy |
124,590
+5,087
| +4% | +$332K | 0.28% | 75 |
|
|
2015
Q1 | $6.99M | Buy |
119,503
+47,767
| +67% | +$2.89M | 0.23% | 89 |
|
|
2014
Q4 | $4.69M | Buy |
71,736
+19,816
| +38% | +$1.25M | 0.15% | 131 |
|
|
2014
Q3 | $2.99M | Sell |
51,920
-27,583
| -35% | -$1.53M | 0.1% | 203 |
|
|
2014
Q2 | $4.48M | Buy |
79,503
+97
| +0.1% | +$5.09K | 0.15% | 126 |
|
|
2014
Q1 | $4.08M | Buy |
79,406
+7,472
| +10% | +$378K | 0.15% | 140 |
|
|
2013
Q4 | $3.8M | Buy |
71,934
+31,815
| +79% | +$1.56M | 0.14% | 136 |
|
|
2013
Q3 | $1.79M | Buy |
40,119
+866
| +2% | +$38.4K | 0.08% | 237 |
|
|
2013
Q2 | $1.62M | Buy |
+39,253
| New | +$1.72M | 0.08% | 242 |
|
Other funds holding ABBV
VCM
VPM
D.A. Davidson & Co's ABBV Position: Q1 2026 in Review
D.A. Davidson & Co increased its AbbVie (ABBV) stake by 0.55% in Q1 2026, buying an estimated $331K and bringing the position to 272,607 shares worth $59.3M. The position accounts for 0.36% of the portfolio, ranked #56.
D.A. Davidson & Co first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $61.9M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- D.A. Davidson & Co held 272,607 shares of AbbVie worth $59.3M as of Q1 2026.
- D.A. Davidson & Co bought 1,491 AbbVie shares in Q1 2026, an estimated $331K.
- AbbVie made up 0.36% of D.A. Davidson & Co's portfolio in Q1 2026, its #56 holding.
- D.A. Davidson & Co first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- D.A. Davidson & Co's AbbVie position peaked at $61.9M in Q4 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.